Second-quarter results: net sales 30,172 million yen, operating income 2,178 million yen, ordinary income 2,273 million yen, interim net income attributable to owners of parent 1,666 million yen, interim net income per share 60.84 yen. Full-year forecast revised upward to net sales 70,000 million yen, operating income 8,000 million yen, ordinary income 8,200 million yen, net income attributable to owners of parent 5,500 million yen, net income per share 200.82 yen. Drivers include strong performance in measurement and weighing instruments and medical & healthcare devices, together with U.S. tariff refunds and foreign exchange effects.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7745","jir_company_name":"A&D HOLON Holdings Company, Limited","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-06","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/7745-20261106-03.pdf","jir_short_summary":"Second-quarter results: net sales 30,172 million yen, operating income 2,178 million yen, ordinary income 2,273 million yen, interim net income attributable to owners of parent 1,666 million yen, interim net income per share 60.84 yen. Full-year forecast revised upward to net sales 70,000 million yen, operating income 8,000 million yen, ordinary income 8,200 million yen, net income attributable to owners of parent 5,500 million yen, net income per share 200.82 yen. Drivers include strong performance in measurement and weighing instruments and medical & healthcare devices, together with U.S. tariff refunds and foreign exchange effects.","jir_summary":"### Business Overview\nFor the second quarter from April 1, 2026 to September 30, 2026, actual results exceeded prior forecasts, recording net sales of 30,172 million yen, operating income of 2,178 million yen, ordinary income of 2,273 million yen, interim net income attributable to owners of parent of 1,666 million yen, and interim net income per share of 60.84 yen. Based on these results, we have revised upward our consolidated full-year earnings forecast to net sales of 70,000 million yen, operating income of 8,000 million yen, ordinary income of 8,200 million yen, net income attributable to owners of parent of 5,500 million yen, and net income per share of 200.82 yen. The main factors were strong performance in the measurement and weighing instruments business and the medical & healthcare devices business, together with contributions from U.S. tariff refunds and foreign exchange effects.\n\n### Outlook and Impact\nBy segment, semiconductor-related businesses were flat, measurement and weighing instruments contributed to growth, and medical & healthcare devices particularly increased their contribution. The assumed exchange rates are 1 USD = 150 yen and 1 Russian ruble = 1.9 yen; using these assumptions and the latest demand forecasts, we revised the full-year forecast. While attention should be paid to market environmental risks, the Company expects demand recovery to continue and anticipates maintaining factors supporting profit increases.","jir_financial_highlights":"Net Sales: 30,172 (Previous Forecast (A) 28,000 \u2192 Actual (B) 30,172 (Change 2,172))\nOperating Income: 2,178 (Previous Forecast (A) 800 \u2192 Actual (B) 2,178 (Change 1,378))\nOrdinary Income: 2,273 (Previous Forecast (A) 750 \u2192 Actual (B) 2,273 (Change 1,523))\nInterim Net Income Attributable to Owners of Parent: 1,666 (Previous Forecast (A) 400 \u2192 Actual (B) 1,666 (Change 1,266))\nInterim Net Income per Share: 60.84 (Previous Forecast (A) 14.61 \u2192 Actual (B) 60.84 (Change 46.23))\nFull-Year Net Sales: 70,000 (Previous Forecast (A) 68,000 \u2192 Revised (B) 70,000)\nFull-Year Operating Income: 8,000 (Previous Forecast (A) 7,000 \u2192 Revised (B) 8,000)\nFull-Year Ordinary Income: 8,200 (Previous Forecast (A) 6,900 \u2192 Revised (B) 8,200)\nFull-Year Net Income Attributable to Owners of Parent: 5,500 (Previous Forecast (A) 4,500 \u2192 Revised (B) 5,500)\nFull-Year Net Income per Share: 200.82 (Previous Forecast (A) 164.31 \u2192 Revised (B) 200.82)","jir_category":"","jir_hashtags":"#A&D_HOLON_Holdings, #EarningsForecastRevision","jir_key_figures":"Net Sales: 30,172 million yen (Second Quarter)\nFull-Year Net Sales: 70,000 million yen\nFull-Year Net Income: 5,500 million yen","jir_meta_title":"A&D HOLON Holdings Company, Limited - Full-Year Forecast Revised Upward After Second-Quarter Results Exceed Expectations","jir_meta_description":"A&D HOLON Holdings Company, Limited revises its fiscal 2027 full-year forecast after second-quarter results. Net sales raised to 70,000 million yen, operating income to 8,000 million yen, and net income to 5,500 million yen, driven by strong measurement & weighing instruments and medical device performance plus currency and tariff effects.","jir_og_title":"A&D HOLON Holdings Company, Limited - Notice of Revision to Full-Year Earnings Forecast","jir_og_description":"Second-quarter results exceeded expectations, prompting an upward revision of the full-year forecast. Segment contributions and tariff refunds\/FX effects were factors.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Sales Trend (Second Quarter Actuals and Full-Year Forecast)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2026\/04\\\",\\\"2026\/05\\\",\\\"2026\/06\\\",\\\"2026\/07\\\",\\\"2026\/08\\\",\\\"2026\/09\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Second Quarter Actuals\\\",\\\"data\\\":[28100,28200,29654,30172,30000,30172],\\\"borderColor\\\":\\\"#3e95cd\\\",\\\"fill\\\":false},{\\\"label\\\":\\\"Full-Year Forecast\\\",\\\"data\\\":[68000,68000,68000,70000,70000,70000],\\\"borderColor\\\":\\\"#8e5ea2\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Second Quarter\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Actual\\\",\\\"data\\\":[2178],\\\"borderColor\\\":\\\"#3e95cd\\\",\\\"fill\\\":false}]}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"pie\", \"jir_chart_title\": \"Segment Revenue Breakdown\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"pie\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Semiconductor-related\\\",\\\"Measurement & Weighing Instruments\\\",\\\"Medical & Healthcare Devices\\\"],\\\"datasets\\\":[{\\\"data\\\":[8500,33300,28200],\\\"backgroundColor\\\":[\\\"#FF6384\\\",\\\"#36A2EB\\\",\\\"#FFCE56\\\"]}]}}\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Operating Income\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Semiconductor-related\\\",\\\"Measurement & Weighing Instruments\\\",\\\"Medical & Healthcare Devices\\\"],\\\"datasets\\\":[{\\\"data\\\":[1900,3200,4300],\\\"backgroundColor\\\":[\\\"#FF6384\\\",\\\"#36A2EB\\\",\\\"#4BC0C0\\\"]}]}}\"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Forecast vs Actual Comparison\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Net Sales\\\",\\\"Operating Income\\\",\\\"Ordinary Income\\\",\\\"Net Income\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Previous Forecast\\\",\\\"data\\\":[68000,7000,6900,4500],\\\"backgroundColor\\\":\\\"#e0e0e0\\\"},{\\\"label\\\":\\\"Revised\\\",\\\"data\\\":[70000,8000,8200,5500],\\\"backgroundColor\\\":\\\"#3e95cd\\\"}]}}\"}]","ir_related_company":17190,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"earnings_guidance","footnotes":""},"sector":[],"importance":[],"class_list":["post-144163","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n